Dr. Padmakar Bommisetty

RbQM l Clinical Project Management | Risk Based Monitoring | Centralized Monitoring | Clinical Development | Oncology

Bengaluru, Karnataka, India

About

Doctorate-trained Biotechnology professional with 18+ years of experience spanning R&D and Clinical Research, including 10+ years in global clinical trials. Expertise in Clinical Development, Risk-Based Monitoring (RBM), and Risk-Based Quality Management (RbQM), with a strong focus on Early and Late Phase studies in Oncology. Currently Associate Director, RbQM (Risk Manager) at AstraZeneca India, leading centralized monitoring and end-to-end risk management for global oncology programs, ensuring quality, compliance, and inspection readiness. Previously held progressive roles at IQVIA and Novartis, driving centralized monitoring operations and clinical development initiatives. Recognized for strengths in Clinical Data Review, Project Management, and quality frameworks including QTLs and CtQ. Certified Base SAS Programmer (SAS 9.0) with 31 scientific publications, reflecting a strong foundation in research and analytics.

Experience

  • AstraZeneca India (3 yrs 9 mos)
    • Associate Director, Risk Based Quality Management
      Apr 2025 - Present · 1 yr 4 mos

    • Senior RBQM Specialist
      Nov 2022 - Present · 3 yrs 9 mos

  • Centralized Monitoring Lead at IQVIA
    Nov 2021 - Nov 2022 · 1 yr 1 mo

  • Clinical Scientific Expert I at Novartis
    Jan 2019 - Nov 2021 · 2 yrs 11 mos

  • IQVIA (3 yrs)
    • Clinical Monitoring Lead
      Nov 2018 - Jan 2019 · 3 mos

    • Centralized Monitor
      Apr 2018 - Jan 2019 · 10 mos

    • Senior Central Monitor - Centralized Monitoring Services
      Oct 2016 - Jan 2019 · 2 yrs 4 mos

  • Research Associate at Indian Institute of Horticultural Research
    Apr 2015 - Jan 2016 · 10 mos